Phase II study of induction platinum doublet in combination with nivolumab followed by surgery or concurrent chemotherapy-nivolumab-radiation in unresectable stage IIIA-C non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Zinner, Ralph
Meyerson, Shari L.
McGarry, Ronald C.
Mullett, Timothy W.
Villano, John L.
Hao, Zhonglin
Yang, Eddy Shih-Hsin
Miller, Jordan D.
Shah-Jadeja, Mansi M.
Morgan, Clinton T.
Maskey, Ashish P.
Bernard, Mark E.
Yan, Weisi
Yan, Donglin
McLouth, Laurie
Ming-Yuan, Boris
Cornette, Abagail L.
Phelps, Mitch A.
Kneuertz, Peter J.
Carbone, David Paul
机构：
[1] Univ Kentucky, Comprehens Canc Ctr, Lexington, KY USA
[2] Univ Kentucky, Coll Dept Behav Hlth, Lexington, KY USA
[3] Univ Kentucky, Dept Human Hlth Sci, Lexington, KY USA
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[5] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[6] Pelotonia Inst Immunooncol, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS8122
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase II study of weekly docetaxel/cisplatin and concurrent radiotherapy followed by surgery in patients with stage III non-small cell lung cancer (NSCLC)
    Maas, K. W.
    Phernambucq, E. C.
    Sharouni, S. Y.
    Stigt, J. A.
    Groen, H. J.
    van den Borne, B. E.
    Senan, S.
    Smit, E. F.
    Paul, R. A.
    Schramel, F. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] A phase II study of weekly docetaxel/cisplatin and concurrent radiotherapy followed by surgery in patients with stage III non-small cell lung cancer (NSCLC)
    Maas, K. W.
    Sharouni, S. Y.
    Phernambucq, E. C.
    Stigt, J. A.
    Groen, H. J.
    van den Borne, B. E.
    Senan, S.
    Paul, R. M.
    Smit, E. F.
    Schramel, F. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation (CCR) with biweekly gemcitabine in unresectable stage III non small cell lung cancer (NSCLC):: Final results of a phase II study
    Blanco, R
    Solé, J
    Nogué, M
    Montesinos, J
    Gallardo, E
    Vadell, C
    Mesía, C
    Algara, M
    Terrasa, J
    LUNG CANCER, 2005, 49 : S77 - S77
  • [34] Phase II study of induction chemotherapy followed by radiotherapy combined with daily cisplatin in stage III inoperable non-small cell lung cancer (NSCLC).
    Scolaro, T
    Ardizzoni, A
    Giudici, S
    Grossi, F
    Cosso, M
    Pennucci, MC
    Bacigalupo, A
    Rosso, R
    Vitale, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 313 - 313
  • [35] Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer
    Yamanaka, Yuta
    Ota, Takayo
    Masuoka, Yutaka
    Takeyasu, Yuki
    Nakamura, Satoaki
    Terashima, Masaaki
    Yoshioka, Hiroshige
    Fukuoka, Masahiro
    Kurata, Takayasu
    CANCERS, 2024, 16 (18)
  • [36] Management of stage IIIA non-small cell lung cancer (NSCLC) role of the chemotherapy
    Baudoux, Nathalie
    Friedlaender, Alex
    Addeo, Alfredo
    CURRENT CHALLENGES IN THORACIC SURGERY, 2022, 4
  • [37] Nivolumab in Non-Small Cell Lung Cancer (NSCLC): A Real-Life Study
    Reis, D.
    Mendes, A.
    China, N.
    Dias, M.
    Coutinho, D.
    Silva, E.
    Campainha, S.
    Costa, T.
    Conde, S.
    Barroso, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S975 - S976
  • [38] Outcomes for Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Treated With Concurrent Chemotherapy and Radiation Therapy to 70 Gy
    Freilich, J.
    Baker, R.
    Stevens, C. W.
    Fulp, W. J.
    DeMarco, M.
    Turke, C.
    Dilling, T. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S572 - S572
  • [39] Outcomes For Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) Treated With Concurrent Chemotherapy And Radiation Therapy To 70 Gy
    Freilich, J.
    Baker, R.
    Stevens, C. W.
    Fulp, W. J.
    DeMarco, M.
    Turke, C.
    Dilling, T. J.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S270 - S270
  • [40] Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non-small cell lung cancer.
    Ferrer, Loic
    Nadal, Ernest
    Guidel, Floriane
    Insa, Amelia
    Menu, Philippe
    Casal, Joaquin
    Domine, Manuel
    Massuti, Bartomeu
    Majem, Margarita
    Martinez-Marti, Alex
    Garcia Campelo, Rosario
    de Castro Carpeno, Javier
    Cobo, Manuel
    Vivanco, Guillermo Lopez
    del Barco, Edel
    Bernabe, Reyes
    Vinolas, Nuria
    Barneto, Isidoro
    Colin, Thierry
    Provencio-Pulla, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345